About 180,000 Moldovans, encompassing over 9,000 children and around 900 expectant mothers, have been diagnosed with the coronavirus disease since the commencement of the pandemic, and over 5,000 people have died because of COVID-19. On March 7, 2020, a Moldovan female passenger returning from the Italian Republic was confirmed positive for the new coronavirus disease, confirming the virus had made its way there (UNICEF, 2021). COVID-19 AstraZeneca vaccine doses were sent to Moldova on March 4, 2021, via the COVAX Facility, in cooperation between the Coalition for Epidemic Preparedness Innovations (CEPI), UNICEF, Gavi, and the World Health Organization (WHO). The Republic of Moldova was the first WHO European Region nation to acquire vaccines as part of the global procurement mechanism of the COVAX Facility.
COVID-19 vaccines have already arrived, marking an important milestone in the effort to ensure fair distribution worldwide in what is expected to be the biggest-ever vaccine provision and distribution operation. Thousands of people have arrived in the Republic of Moldova in recent weeks, and this shipment is part of that first influx. A vaccine to protect vulnerable populations was made available to every COVAX participant economy during the first half of 2021 (UNICEF, 2021). To reach up to 20% of the world’s population by the end of the year, 92 economies qualifying for the COVAX commitment will receive about 1.3 billion donation doses, including Moldova.
The Moldovan Ministry of Health is thankful to the COVAX platform for providing free vaccinations to the country, the first in Europe. The 14,000 dosages of the coronavirus disease vaccine that Moldova will get will go a long way toward protecting the country’s healthcare professionals against the virus and halting its spread. To all the countries and agencies that have contributed monetarily to this worldwide platform, Moldova’s Ministry of Health extends its gratitude, including Japan, European Union member states, the European Commission, the US, Canada, the UK, and others. In these trying times, these countries and organizations have shown their allegiance to the common good (UNICEF, 2021). In addition, WHO and UNICEF have made enormous efforts to distribute vaccinations fairly. COVID-19 vaccines from Pfizer and AstraZeneca will be delivered to the Republic of Moldova via the COVAX Facility in 2021, with up to 264,000 doses.
Vaccines are an important new weapon in the fight against coronavirus and the rising rate of infection, together with other public health measures to prevent transmission, including following testing and quarantine procedures. Other important practices encompass wearing masks, practicing good hand hygiene, and physically separating oneself from sick people. Ending the epidemic will need equitable and fair access to vaccinations for all. The EU and its allies, working as ‘Team Europe,’ feel delighted to assist COVAX in distributing vaccinations to all its partners throughout the world. Europe has been and will be a solid ally in this endeavor (Luo et al., 2021). The US aids Moldova’s highly disadvantaged and at-risk populace, particularly frontline medical workers, through the COVAX Facility, which purchases and delivers effective vaccinations. These vaccinations are crucial to stop the COVID-19 pandemic and give people hope for a better and brighter future.
UNICEF is utilizing its expertise as the world’s biggest single buyer of vaccines and working with producers and partners to acquire COVID-19 vaccination doses, along with shipping, logistics, and preservation. Vaccines rank at the top of the medical innovation scale (Agyekum et al., 2021). The only way out of this problem is to have a reliable supply of vaccinations, and this must be made available to everyone. Moldova began immunizing frontline health workers with AstraZeneca’s COVID-19 vaccine on March 2, after Romania sent the first contribution on February 27, 2021. To help combat the spread of COVID-19, the COVAX Facility, a collaboration between Gavi, CEPI, WHO, and UNICEF, sent 24,570 doses of the Pfizer vaccine to Moldova on March 19, 2021. The shipment has now arrived in Moldova for the second time. Covid-19 immunization has begun in Moldova, and the supply of vaccines provided by the COVAX policy will enable the country to immunize other population groups. Vaccine distribution has been sped up thanks to collaboration with development partners.
International availability of safe and successful COVID-19 vaccinations is being accelerated thanks to an unprecedented $4 billion investment from the United States through USAID, the Vaccine Alliance. A safe and effective COVID-19 vaccination for vulnerable and at-risk people throughout the globe will be supported by Gavi, including frontline healthcare professionals. These Pfizer-made vaccinations will help save lives and aid Moldova in its battle against the pandemic, both of which will be made possible by this shipment (Nzaji et al., 2020). Having a fresh supply of anti-COVID vaccination on hand is welcome news as Moldova works to get as many individuals vaccinated as possible and as fast as feasible. The government of Moldova is comforted by the fact that more physicians and nurses in the nation will be protected in their efforts to save more lives in the future. In light of the virus’s fast spread, it is clear that no one country can stop this global pandemic on its own. The United States government is speeding up global access to anti-COVID-19 vaccinations in collaboration with the international community through USAID.
The EU and its allies have expressed their continuing support in the spirit of collaboration to supply urgently needed vaccinations to Moldova. According to the COVAX platform, which the EU and Team Europe heavily subsidize, vaccines are still being delivered, as seen by the recent shipment to Moldova. This parcel will make it possible to vaccinate even more people, which will result in even more lives being saved. For the epidemic to be brought to a close, vaccination access must be improved (Ahmed et al., 2021). United Nations Moldova has given urgent assistance to the nation in three major areas: the medical system readiness, technological support and capability development, and data and announcements on COVID-19 since the beginning of the pandemic. The government of Moldova is convinced that the new consignment of vaccines will generate the maximum impact on health by strengthening the nation to guard its caregivers and other people at a high risk of infection, reinforcing the values of fairness, intelligibility, and impartiality that steered the vaccine distribution process.
One of the main aspects of the fight against the COVID-19 pandemic was the passion and commitment of healthcare personnel to publicizing the advantages of vaccinations. As the most trusted source of information about vaccination, healthcare workers (HCWs) play a crucial role in developing public faith in the immunization program (Obregon et al., 2020). It is consequently imperative that healthcare providers be convinced of the value of immunization and are able to communicate this confidence to the population at large. HCWs, like the general public, are vulnerable to vaccination disinformation, particularly in the wake of the infodemic that has stoked public distrust and raised questions about the safety of vaccines, hampering the international effort to alleviate the effects of the COVID-19 pandemic. The number of people intending to get the COVID-19 vaccine is rather small in scope.
Patient acceptance, immunization, adherence to vaccine schedules, and decreased aversion are all related to healthcare providers’ attitudes about and use of vaccination. Patients’ decisions to receive vaccination are influenced significantly by HCWs who have received the vaccine. Additionally, vaccination hesitation in the public has been related to vaccine uncertainty among HCWs on a regular basis (Alhumaid et al., 2021). It has been proven that healthcare professionals’ educational material regarding vaccines, including the quality, substance, and dissemination, helps patients accept immunizations, reduce resistance, and make educated vaccination decisions. Healthcare professionals have a strong relationship with patients because they are trusted to provide accurate information about vaccinations and diseases that may be prevented with vaccines, as well as about vaccines’ therapeutic and public health advantages. Globally, the general people’s trust in vaccinations is declining, which presents a serious problem for public health specialists. Healthcare workers are an essential group to examine despite the fact that there are several influencers. COVID-19 vaccinations must be given to caregivers since they are at the front line of the COVID-19 pandemic and are an important target group.
Long-term tackling of the COVID-19 pandemic will be difficult if people are uncertain or unwilling to take vaccines. As a result, frontline healthcare employees with patient-facing responsibilities will be in high demand. Those who are on the front lines of health care have a greater chance of contracting an infection and spreading it (Dror et al., 2020). Healthcare personnel is to blame for the huge number of people who have been infected by the COVID-19 epidemic. Infected individuals can readily spread the coronavirus illness to healthy people because healthcare personnel is exposed and sensitive to it. The immunization of healthcare professionals may, therefore, be advantageous to them as well as to their families and patients. Concerns regarding vaccination safety should be addressed as soon as feasible among healthcare professionals who will be receiving vaccinations for the first time.
The coronavirus pandemic continues to spread, with more people being infected and dying as a result. Many vaccinations have been developed to combat deadly diseases (Re et al., 2021). As a consequence of the findings of the study, all stakeholders and medical institutions, including the federal department of health, will be better equipped to determine when, where, and how much vaccination services should be provided. The study’s findings will also aid in overcoming any flaws in vaccination schedule advancement.
The breadth of COVID-19 immunizations amongst health professionals and the rest of the population is still affected by the intention to get the vaccine. The readiness of healthcare workers in Moldova to obtain COVID -19 vaccinations is still a question that has not been answered. Because more healthcare workers in Moldova are accepting the vaccination against Covid-19, the vaccine may be distributed more swiftly, protecting them as frontline workers (Temsah et al., 2021). Accordingly, the goal of this research was to investigate if health professionals working in Moldova intend to get the COVID-19 vaccination and what factors would influence their willingness to take it. This study will test the hypothesis that: improving caregivers’ attitudes, understanding, and perceptions of the COVID-19 vaccination will have no effect on public acceptance of vaccines as a preventative measure against the pandemic.
Reference List
Agyekum, M.W., Afrifa-Anane, G.F., Kyei-Arthur, F. and Addo, B. (2021) ‘Acceptability of COVID-19 vaccination among health care workers in Ghana’, Advances in Public Health, 1, pp. 1-13.
Ahmed, M., Kanfe, S. and Jarso, M. (2021) ‘Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings’, PloS One, 16(7), pp. 1-13.
Alhumaid, S., Al Mutair, A., Al Alawi, Z., Alsuliman, M., Ahmed, G.Y., Rabaan, A., Al-Tawfiq, J. and Al-Omari, A. (2021) ‘Knowledge of infection prevention and control among healthcare workers and factors influencing compliance: a systematic review’, Antimicrobial Resistance & Infection Control, 10(1), pp. 1-32.
Dror, A., Eisenbach, N., Taiber, S., Morozov, N., Mizrachi, M., Zigron, A., Srouji, S. and Sela, E. (2020) ‘Vaccine hesitancy: the next challenge in the fight against COVID-19’, European Journal of Epidemiology, 35(8), pp. 775-779.
Luo, C., Yang, Y., Liu, Y., Zheng, D., Shao, L., Jin, J. and He, Q. (2021) ‘Intention to COVID-19 vaccination and associated factors among health care workers: a systematic review and meta-analysis of cross-sectional studies’, American Journal of Infection Control, 49(10), pp. 1295-1304.
Nzaji, M., Ngombe, L., Mwamba, G., Ndala, D., Miema, J., Lungoyo, C., Mwimba, B., Bene, A. and Musenga, E. (2020) ‘Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo’, Pragmatic and Observational Research, 11, pp. 103-110.
Obregon, R., Mosquera, M., Tomsa, S. and Chitnis, K. (2020) ‘Vaccine hesitancy and demand for immunization in Eastern Europe and Central Asia: implications for the region and beyond’, Journal of Health Communication, 25(10), pp. 808-815.
Re, V.L., Klungel, O.H., Chan, K.A., Panozzo, C.A., Zhou, W. and Winterstein, A.G. (2021) Global covid-19 vaccine rollout and safety surveillance- how to keep pace. British Medical Journal, 373, pp. 1-12.
Temsah, M., Barry, M., Aljamaan, F., Alhuzaimi, A., Al-Eyadhy, A., Saddik, B., Alrabiaah, A., Alsohime, F., Alhaboob, A., Alhasan, K. and Alaraj, A. (2021) ‘Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey’, BMJ Open, 11(6), pp. 1-9.